Suppr超能文献

伊维菌素单剂量400微克/千克:治疗班氏丝虫病的最有效剂量。

Single doses of ivermectin 400 micrograms/kg-1: the most effective dosage in bancroftian filariasis.

作者信息

Moulia-Pelat J P, Glaziou P, Nguyen L N, Cartel J L

机构信息

Institut Territorial de Recherches Médicales Louis Malardé, Papeete, Tahiti, French Polynesia.

出版信息

Southeast Asian J Trop Med Public Health. 1995 Mar;26(1):124-7.

PMID:8525398
Abstract

Forty-three Wuchereria bancrofti carriers were given four successive semi-annual single doses of ivermectin 100 micrograms.kg-1 (IVER 100). The geometric mean microfilaremia (mf) recurrence percentage as compared to the pre-initial treatment mf level was 35%, 21%, 17% and 17% at 6, 12, 18 and 24 months, respectively. However, the recurrence of mf 6 months after the fourth treatment remained high in several individuals: 15 have been considered as 'bad responders' and 28 as 'good responders' individuals. At month 24 (M 24), they were randomly allocated into 2 groups. A first group was treated with a fifty and a sixth dose of IVER 100, at M24 and M30, respectively; the second one was treated, at the same time, with single doses of IVER 400 micrograms.kg-1 (IVER 400). At M 36, the mf recurrence percentage (mf M36/mf M0) was significantly higher in patients treated with IVER 100 than IVER 400 (11% vs 1%, p < 10(-4). From the group IVER 100, 6 out of the 8 'bad responders' remained 'bad responders' whereas there were none of the 7 in the group IVER 400. Moreover, there were only 2 more patients in the group IVER 100 showing sustained complete zero mf, whereas they were 13 in the group IVER 400. Single doses of IVER 400 were effective on 'bad responders'; IVER 400 must be recommended for semi-annual mass treatment in bancroftian filariasis.

摘要

43名班氏吴策线虫携带者每半年连续单剂量服用4次100微克/千克的伊维菌素(IVER 100)。与初始治疗前的微丝蚴血症(mf)水平相比,在6、12、18和24个月时,几何平均微丝蚴血症复发率分别为35%、21%、17%和17%。然而,在第四次治疗6个月后,仍有若干个体的mf复发率较高:15人被视为“反应不佳者”,28人被视为“反应良好者”。在24个月时(M 24),他们被随机分为2组。第一组分别在M24和M30时接受第五和第六剂IVER 100治疗;第二组同时接受单剂量400微克/千克的伊维菌素(IVER 400)治疗。在M 36时,接受IVER 100治疗的患者的mf复发率(mf M36/mf M0)显著高于接受IVER 400治疗的患者(11%对1%,p < 10(-4))。在IVER 100组中,8名“反应不佳者”中有6人仍为“反应不佳者”,而在IVER 400组的7人中则无人如此。此外,IVER 100组中仅有2名患者持续完全无mf,而IVER 400组中有13名。单剂量的IVER 400对“反应不佳者”有效;在班氏丝虫病的半年大规模治疗中,必须推荐使用IVER 400。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验